The importance of glucocorticoid and immunosuppressive therapy in the treatment of this rare chronic inflammatory disease, which can be confused with many clinical conditions, has been mentioned.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Immunoglobulin G4(IgG4) related disease (IgG4-RD) is a chronic fibro-inflammatory condition characterized by immunohistochemically positive IgG4-positive plasma cell infiltrates in the tissues, elevated serum IgG4 levels, and fibrosis in the affected organs.
📊
Temel Bulgular & Veri:Besides, serum IgG4 levels were found to be increased and IgG4 related disease was diagnosed.
💡
Sonuç & Katkı:The importance of glucocorticoid and immunosuppressive therapy in the treatment of this rare chronic inflammatory disease, which can be confused with many clinical conditions, has been mentioned.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
Immunoglobulin G4(IgG4) related disease (IgG4-RD) is a chronic fibro-inflammatory condition characterized by immunohistochemically positive IgG4-positive plasma cell infiltrates in the tissues, elevated serum IgG4 levels, and fibrosis in the affected organs. The most frequent complaints are associated with obstructive phlebitis, mass and tumor-like tissue swelling. Our case was admitted with a complaint of breast mass, and lymphocyte infiltration, dense fibrosis foci were detected in the breast biopsy. Besides, serum IgG4 levels were found to be increased and IgG4 related disease was diagnosed. The importance of glucocorticoid and immunosuppressive therapy in the treatment of this rare chronic inflammatory disease, which can be confused with many clinical conditions, has been mentioned.
🔖
Bu Makaleye Atıf Yap
ÇINAR, M., TEKGÖZ, E., AKINCIOĞLU, E., SAFALI, M., YILMAZ, S. (2018). Immune globulin G4 associated disease: Immunosuppressive treatment should be considered. Gülhane Tıp Dergisi, Cilt: 60 - Sayı: 1, 30–32. https://ajindex.com/articles/167578
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366: 539–551.
Takahashi H, Yamamoto M, Suzuki C, Naishiro Y, Shinomura Y, Imai K. The birthday of a new syndrome: IgG4- related disease constitute a clinical entity. Autoimmun Rev 2010;9:591–594.
Wu Q, Chang J, Chen H, et al. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial. Int J Rheum Dis 2017;20(5):639-646.
Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 2010;39(5):549–554.
Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011;40(3):352–358.
Umehara H, Okazaki K. Comprehensive diagnostic criteria for IgG4-related disease: IgG4-related disease, Tokyo. Springer 2013;35–39.
Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol 2010;37:1380. Guma M, Firestein GS. IgG4-related diseases. Best Pract Res Clin Rheumatol 2012;26:425–438.
Beyer G, Schwaiger T, Lerch MM, Mayerle J. IgG4- related disease: a new kid on the block or an old aquaintance. United European Gastroenteroloji 2014;2(3):165–172.
Huggett MT, Culver EL, Kumar M, et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. The American journal of gastroenterology 2014; 109(10):1675-1683.
Khosroshahi A, Stone JH. Treatment approaches to IgG4- related systemic disease. Curr Opin Rheumatol 2011;23(1):67–71.
Mannion M, Cron RQ. Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature. Pediatr Rheumatol 2011;9:1.